Comparazione clinica di differenti formule di latte sostitutivo in bambini con allergia alle proteine del latte vaccino

Follow-up a 24 mesi

Translated title of the contribution: Clinical comparison of different replacement milk formulas in children with allergies to cow's milk proteins. 24-month follow-up

E. Galli, L. Chini, F. Paone, V. Moschese, D. Knafelz, P. Panel, E. Emanuele, D. Palermo, A. Di Fazio, P. Rossi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The elective treatment for allergy to cow's milk protein is the elimination of these proteins from the diet. The present study with a follow-up of over two years took the form of a comparison between different replacement formulas based on soya (group A), hydrolysate of soya and bovine collagen (group B), and hydrolysate of casein (group C), randomly administered to 55 children (30 males and 25 females, aged between 2-48 months) with documented allergy to cow's milk proteins, but with different clinical symptoms. Tests to evaluate the acquisition of clinical tolerance to cow's milk proteins were performed using a day-hospital regime evey 6 months. Sensitivity reactions were observed in 22% of cases in group A, 8% in group B and 37.5% in group C. It is worth underlining that 5 of the 6 children with reactions to soya protein then showed an excellent tolerance to hydrolysate of soya when it was administered subsequently until tolerance was achieved. weight and statutory growth was uniformly good in all three groups. A high percentage of children achieved tolerance after 24 months (72%); the mean time taken to acquire clinical tolerance was 11.6±4.8 in group A, 11.6±6.02 in group B, and 14±5.6 in group C. No correlation was found between the type of initial symptoms, age at onset, method of response to first challenge and the time taken to acquire tolerance.

Original languageItalian
Pages (from-to)71-77
Number of pages7
JournalMinerva Pediatrica
Volume48
Issue number3
Publication statusPublished - Mar 1996

Fingerprint

Milk Proteins
Hypersensitivity
Milk
Age of Onset
Proteins
Collagen
Diet
Weights and Measures
Growth
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Comparazione clinica di differenti formule di latte sostitutivo in bambini con allergia alle proteine del latte vaccino : Follow-up a 24 mesi. / Galli, E.; Chini, L.; Paone, F.; Moschese, V.; Knafelz, D.; Panel, P.; Emanuele, E.; Palermo, D.; Di Fazio, A.; Rossi, P.

In: Minerva Pediatrica, Vol. 48, No. 3, 03.1996, p. 71-77.

Research output: Contribution to journalArticle

Galli, E, Chini, L, Paone, F, Moschese, V, Knafelz, D, Panel, P, Emanuele, E, Palermo, D, Di Fazio, A & Rossi, P 1996, 'Comparazione clinica di differenti formule di latte sostitutivo in bambini con allergia alle proteine del latte vaccino: Follow-up a 24 mesi', Minerva Pediatrica, vol. 48, no. 3, pp. 71-77.
Galli, E. ; Chini, L. ; Paone, F. ; Moschese, V. ; Knafelz, D. ; Panel, P. ; Emanuele, E. ; Palermo, D. ; Di Fazio, A. ; Rossi, P. / Comparazione clinica di differenti formule di latte sostitutivo in bambini con allergia alle proteine del latte vaccino : Follow-up a 24 mesi. In: Minerva Pediatrica. 1996 ; Vol. 48, No. 3. pp. 71-77.
@article{f31f331361b1460da5d095217b7487d2,
title = "Comparazione clinica di differenti formule di latte sostitutivo in bambini con allergia alle proteine del latte vaccino: Follow-up a 24 mesi",
abstract = "The elective treatment for allergy to cow's milk protein is the elimination of these proteins from the diet. The present study with a follow-up of over two years took the form of a comparison between different replacement formulas based on soya (group A), hydrolysate of soya and bovine collagen (group B), and hydrolysate of casein (group C), randomly administered to 55 children (30 males and 25 females, aged between 2-48 months) with documented allergy to cow's milk proteins, but with different clinical symptoms. Tests to evaluate the acquisition of clinical tolerance to cow's milk proteins were performed using a day-hospital regime evey 6 months. Sensitivity reactions were observed in 22{\%} of cases in group A, 8{\%} in group B and 37.5{\%} in group C. It is worth underlining that 5 of the 6 children with reactions to soya protein then showed an excellent tolerance to hydrolysate of soya when it was administered subsequently until tolerance was achieved. weight and statutory growth was uniformly good in all three groups. A high percentage of children achieved tolerance after 24 months (72{\%}); the mean time taken to acquire clinical tolerance was 11.6±4.8 in group A, 11.6±6.02 in group B, and 14±5.6 in group C. No correlation was found between the type of initial symptoms, age at onset, method of response to first challenge and the time taken to acquire tolerance.",
keywords = "Milk allergy, Replacement formulas, Tolerance",
author = "E. Galli and L. Chini and F. Paone and V. Moschese and D. Knafelz and P. Panel and E. Emanuele and D. Palermo and {Di Fazio}, A. and P. Rossi",
year = "1996",
month = "3",
language = "Italian",
volume = "48",
pages = "71--77",
journal = "Minerva Pediatrica",
issn = "0026-4946",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Comparazione clinica di differenti formule di latte sostitutivo in bambini con allergia alle proteine del latte vaccino

T2 - Follow-up a 24 mesi

AU - Galli, E.

AU - Chini, L.

AU - Paone, F.

AU - Moschese, V.

AU - Knafelz, D.

AU - Panel, P.

AU - Emanuele, E.

AU - Palermo, D.

AU - Di Fazio, A.

AU - Rossi, P.

PY - 1996/3

Y1 - 1996/3

N2 - The elective treatment for allergy to cow's milk protein is the elimination of these proteins from the diet. The present study with a follow-up of over two years took the form of a comparison between different replacement formulas based on soya (group A), hydrolysate of soya and bovine collagen (group B), and hydrolysate of casein (group C), randomly administered to 55 children (30 males and 25 females, aged between 2-48 months) with documented allergy to cow's milk proteins, but with different clinical symptoms. Tests to evaluate the acquisition of clinical tolerance to cow's milk proteins were performed using a day-hospital regime evey 6 months. Sensitivity reactions were observed in 22% of cases in group A, 8% in group B and 37.5% in group C. It is worth underlining that 5 of the 6 children with reactions to soya protein then showed an excellent tolerance to hydrolysate of soya when it was administered subsequently until tolerance was achieved. weight and statutory growth was uniformly good in all three groups. A high percentage of children achieved tolerance after 24 months (72%); the mean time taken to acquire clinical tolerance was 11.6±4.8 in group A, 11.6±6.02 in group B, and 14±5.6 in group C. No correlation was found between the type of initial symptoms, age at onset, method of response to first challenge and the time taken to acquire tolerance.

AB - The elective treatment for allergy to cow's milk protein is the elimination of these proteins from the diet. The present study with a follow-up of over two years took the form of a comparison between different replacement formulas based on soya (group A), hydrolysate of soya and bovine collagen (group B), and hydrolysate of casein (group C), randomly administered to 55 children (30 males and 25 females, aged between 2-48 months) with documented allergy to cow's milk proteins, but with different clinical symptoms. Tests to evaluate the acquisition of clinical tolerance to cow's milk proteins were performed using a day-hospital regime evey 6 months. Sensitivity reactions were observed in 22% of cases in group A, 8% in group B and 37.5% in group C. It is worth underlining that 5 of the 6 children with reactions to soya protein then showed an excellent tolerance to hydrolysate of soya when it was administered subsequently until tolerance was achieved. weight and statutory growth was uniformly good in all three groups. A high percentage of children achieved tolerance after 24 months (72%); the mean time taken to acquire clinical tolerance was 11.6±4.8 in group A, 11.6±6.02 in group B, and 14±5.6 in group C. No correlation was found between the type of initial symptoms, age at onset, method of response to first challenge and the time taken to acquire tolerance.

KW - Milk allergy

KW - Replacement formulas

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=0030096997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030096997&partnerID=8YFLogxK

M3 - Articolo

VL - 48

SP - 71

EP - 77

JO - Minerva Pediatrica

JF - Minerva Pediatrica

SN - 0026-4946

IS - 3

ER -